IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease (Q82669504)
Jump to navigation
Jump to search
scientific article published on 01 February 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease |
scientific article published on 01 February 2010 |
Statements
IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease (English)
L Naumann
E Feist
A Natusch
S Langen
A Krause
F Buttgereit
G-R Burmester
1 February 2010